<DOC>
	<DOC>NCT01996683</DOC>
	<brief_summary>safety and efficacy of different iron chelation therapy in transfusion dependent beta-thalaasemia patients with low serum ferritin and continued regular transfusion regimen.</brief_summary>
	<brief_title>Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (&lt; 500 ng/ml)</brief_title>
	<detailed_description>Treatment of transfusional iron overload in TM patients with low serum ferritin (continued decrease in serum ferritin ) even after reduction of chelation dose.</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Deferiprone</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>â€¢ Subjects with low transfusional iron overload secondary to thalassemia major showing downwardtrend in SF over last 6 months ( 2 readings are needed). Thalassemia major patients with SF equal or less than 500 after reduction of chelation dose. Patients on different types of chelation monotherapy will be included The subjects must also have a level of understanding and willingness to cooperate with the confinement and procedures described in the consent form and scheduled by the study site. In addition, he/she must be able to provide voluntary written informed assent or consent forms. subjects with HIV positive or have active HCV. A history of serious immunologic hypersensitivity to any medication such as anaphylaxis or angioedema. Participation in a previous investigational drug study within the 30 days preceding screening. A woman of childbearing potential must have a negative serum pregnancy test at screening. She must use a medically acceptable form of birth control during the study and for a month afterwards who are pregnant or breastfeeding. An inability to adhere to the designated procedures and restrictions of this protocol.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>B-thalassemia</keyword>
	<keyword>ferritin</keyword>
</DOC>